Suppr超能文献

抗人脂蛋白脂肪酶抗体。

Antibody against human lipoprotein lipase.

作者信息

Etienne J, Noé L, Millot F, Laruelle P, Debray J

出版信息

Atherosclerosis. 1987 Apr;64(2-3):201-9. doi: 10.1016/0021-9150(87)90247-4.

Abstract

A polyclonal antibody against human lipoprotein lipase (LPL) was prepared. LPL from post-heparin plasma was first purified by heparin Sepharose 4B affinity chromatography. Protein impurities co-eluted with LPL were then eliminated by electrophoresis in the presence of ampholytes. Antithrombin III was identified in this fraction of protein impurities by immunodiffusion against a human antithrombin antiserum, while no antithrombin III could be detected in the purified LPL fraction. Immunodiffusion revealed a single line of precipitation between this antibody and human post-heparin plasma LPL. When pre-incubated with a constant activity of highly purified post-heparin plasma LPL (2.7 mU/75 microliters), an equal volume of the anti-LPL antiserum, either pure or diluted to 1/32 caused complete inhibition of the enzyme activity. Half maximal inhibition was observed at a dilution of approximately 1/200. By using a secondary antibody, it was shown that antiserum inhibited LPL activity by means of its immunoglobulins. This antibody was able to inhibit LPL from human adipose tissue, indicating that human LPL released from endothelial cell membranes has common antigenic determinants with adipose tissue LPL.

摘要

制备了一种抗人脂蛋白脂肪酶(LPL)的多克隆抗体。首先通过肝素琼脂糖4B亲和色谱法从肝素后血浆中纯化LPL。然后在两性电解质存在下通过电泳去除与LPL共洗脱的蛋白质杂质。通过与人抗凝血酶抗血清的免疫扩散在该蛋白质杂质部分中鉴定出抗凝血酶III,而在纯化的LPL部分中未检测到抗凝血酶III。免疫扩散显示该抗体与肝素后血浆LPL之间有一条沉淀线。当与恒定活性的高纯度肝素后血浆LPL(2.7 mU/75微升)预孵育时,等体积的抗LPL抗血清,无论是纯的还是稀释至1/32,都能完全抑制酶活性。在约1/200的稀释度下观察到半数最大抑制。通过使用二抗表明抗血清通过其免疫球蛋白抑制LPL活性。该抗体能够抑制来自人脂肪组织的LPL,表明从内皮细胞膜释放的人LPL与脂肪组织LPL具有共同的抗原决定簇。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验